BioCentury
ARTICLE | Company News

Millendo, OvaScience merge, raise $50M

December 14, 2018 6:33 PM UTC

Emerging from the reverse-merger of private endocrine company Millendo Therapeutics Inc. and former public fertility company OvaScience Inc., Millendo Therapeutics Inc. (NASDAQ:MLND) raised $49.5 million in a financing Friday. The combined company will begin trading Dec. 10.

Investors participating in the financing include Great Point Partners, New Enterprise Associates, Frazier Healthcare Partners, Roche Venture Fund, Innobio managed by Bpifrance, Osage University Partners, Altitude Life Science Ventures, Adams Street Partners and Longwood Fund. Jefferies and Leerink were placement agents...